HU896124D0 - Process for the preparation of novel serine-protein-inhibitor proteins, pharmaceutical compositions thereof, preparation of dna sequences encoding for these proteins and expression vectors containing dna sequences - Google Patents

Process for the preparation of novel serine-protein-inhibitor proteins, pharmaceutical compositions thereof, preparation of dna sequences encoding for these proteins and expression vectors containing dna sequences

Info

Publication number
HU896124D0
HU896124D0 HU896124A HU612489A HU896124D0 HU 896124 D0 HU896124 D0 HU 896124D0 HU 896124 A HU896124 A HU 896124A HU 612489 A HU612489 A HU 612489A HU 896124 D0 HU896124 D0 HU 896124D0
Authority
HU
Hungary
Prior art keywords
proteins
dna sequences
synthesis
dna
preparation
Prior art date
Application number
HU896124A
Other languages
English (en)
Other versions
HUT54208A (en
Inventor
Regina Heinzel-Wieland
Joachim Ammann
Gerd Josef Steffens
Leopold Flohe
Original Assignee
Gruenenthal Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruenenthal Gmbh filed Critical Gruenenthal Gmbh
Publication of HU896124D0 publication Critical patent/HU896124D0/hu
Publication of HUT54208A publication Critical patent/HUT54208A/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
HU896124A 1988-12-13 1989-11-22 Process for producing new serine protease inhibitor proteins, pharmaceutical compositions comprising same, dna sequences coding for such proteins and expression vectors containing such dna sequences HUT54208A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3841873A DE3841873A1 (de) 1988-12-13 1988-12-13 Neue serinprotease-inhibitor-proteine, diese enthaltende arzneimittel, dna-sequenzen, die fuer diese proteine codieren und verfahren zur herstellung dieser proteine, arzneimittel und dna-sequenzen

Publications (2)

Publication Number Publication Date
HU896124D0 true HU896124D0 (en) 1990-02-28
HUT54208A HUT54208A (en) 1991-01-28

Family

ID=6369020

Family Applications (1)

Application Number Title Priority Date Filing Date
HU896124A HUT54208A (en) 1988-12-13 1989-11-22 Process for producing new serine protease inhibitor proteins, pharmaceutical compositions comprising same, dna sequences coding for such proteins and expression vectors containing such dna sequences

Country Status (13)

Country Link
EP (1) EP0373335B1 (hu)
JP (1) JP2915032B2 (hu)
AT (1) ATE161019T1 (hu)
AU (1) AU618430B2 (hu)
CA (1) CA2002047A1 (hu)
DE (2) DE3841873A1 (hu)
DK (1) DK625889A (hu)
ES (1) ES2112826T3 (hu)
HK (1) HK1005337A1 (hu)
HU (1) HUT54208A (hu)
IL (1) IL92170A0 (hu)
PT (1) PT92552B (hu)
ZA (1) ZA898395B (hu)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1144488A (zh) * 1994-03-23 1997-03-05 东京田边制药株式会社 新型呼吸道病毒性疾病治疗药物
DE19800363A1 (de) * 1998-01-08 1999-07-15 Forssmann Wolf Georg Prof Dr Serin-Proteinase-Inhibitoren

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4760130A (en) * 1984-12-06 1988-07-26 Synergen Biologicals, Inc. Serine protease inhibitors and methods for isolation of same
ATE92935T1 (de) * 1984-12-06 1993-08-15 Synergen Biolog Inc Serinproteaseinhibitoren und isolierungsverfahren dazu.
DE3600571A1 (de) * 1986-01-10 1987-08-06 Gruenenthal Gmbh Dna-sequenzen, die fuer proteine mit der biologischen aktivitaet der husi-typi-inhibitoren codieren, gentechnologische verfahren zur herstellung dieser proteine und diese proteine enthaltende arzneimittel
CA1340877C (en) * 1987-12-28 2000-01-18 Takashi Sugiyama Elastase inhibitory polypeptide and process for production thereof by recombinant gene technology

Also Published As

Publication number Publication date
ES2112826T3 (es) 1998-04-16
DE58909824D1 (de) 1998-01-22
DK625889D0 (da) 1989-12-12
ZA898395B (en) 1990-10-31
CA2002047A1 (en) 1990-06-13
AU4602689A (en) 1990-06-21
IL92170A0 (en) 1990-07-12
JP2915032B2 (ja) 1999-07-05
ATE161019T1 (de) 1997-12-15
EP0373335A2 (de) 1990-06-20
PT92552B (pt) 1999-02-26
JPH03123490A (ja) 1991-05-27
EP0373335A3 (de) 1990-08-22
HK1005337A1 (en) 1998-12-31
DK625889A (da) 1990-06-14
HUT54208A (en) 1991-01-28
PT92552A (pt) 1990-06-29
DE3841873A1 (de) 1990-06-21
EP0373335B1 (de) 1997-12-10
AU618430B2 (en) 1991-12-19

Similar Documents

Publication Publication Date Title
DE3685885D1 (de) Oligopeptide sowie zwischenprodukte und verfahren zu ihrer herstellung.
ATE363535T1 (de) Stabile bakterizide proteine, welche die permeabilität erhöhen und pharmazeutische zusammensetzungen, diese enthaltend
CA2334941A1 (en) Tnf-derived peptides for use in treating oedema
MY147920A (en) Antibacterial and antiviral peptides from actinomadura namibiensis
HU896124D0 (en) Process for the preparation of novel serine-protein-inhibitor proteins, pharmaceutical compositions thereof, preparation of dna sequences encoding for these proteins and expression vectors containing dna sequences
MXPA02012308A (es) Nuevo interferon para el tratamiento de esclerosis multiple.

Legal Events

Date Code Title Description
DFD9 Temporary protection cancelled due to non-payment of fee